The value of innovation in decision-making in health care in Central Eastern Europe: The sixth international conference, 2 June 2017, Belgrade, Serbia

Tanja Novakovic, Antony P. Martin, Mark Parker, Alessandra Ferrario, Simo Vukovic, Krzysztof Łanda, Jaroslav Duba, Dávid Dankó, Nikolaos Kotsopoulos, Brian Godman, Jelena Ristic, Danka Stefanovic, Danka Tesic

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
9 Downloads (Pure)


The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.
Original languageEnglish
Pages (from-to)519-521
Number of pages3
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Issue number6
Early online date9 Oct 2017
Publication statusPublished - 31 Dec 2017


  • managed entry agreements
  • health technology assessment
  • innovation
  • Central and Eastern Europe

Cite this